Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who are taking statins and develop unexplained, persistent myalgia with a normal plasma creatinine kinase level~Exclusion Criteria:~* Women of childbearing potential~* Patients currently taking coenzyme Q10 (or have taken in the previous 30 days)~* Patients receiving concomitant niacin, fibric acid derivatives, bile acid sequestrants, or other drugs that effect cholesterol levels or interact with statins~* Patients with a history of alcoholism or malnutrition~* Patients who have had acute coronary syndrome or muscle trauma in the prior 7 days~* Patients with a history of chronic muscle/joint pain, fibromyalgia, or degenerative disk disease.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).